Table 3.
Univariate and multivariate analysis of OS.
| Variables | Median OS (months) |
P value | |
|---|---|---|---|
| Univariate | Multivariate | ||
| Gender | |||
| Male | 35.54 ± 5.08 | 0.347 | |
| Female | 22.95 ± 1.95 | ||
| Age (years) | |||
| <60 | 38.26 ± 3.02 | 0.454 | |
| ≥60 | 26.59 ± 6.34 | ||
| KPS | |||
| <90 | 38.46 ± 6.30 | 0.606 | |
| ≥90 | 30.82 ± 6.26 | ||
| HBsAg | |||
| Negative | 22.95 ± 5.58 | 0.476 | |
| Positive | 37.67 ± 3.90 | ||
| Total bilirubin (µmol/L) | |||
| ≤34 | 37.25 ± 3.99 | 0.209 | |
| >34 | 12.85 ± 4.43 | ||
| Albumin (g/L) | |||
| ≤35 | 28.49 ± 6.28 | 0.317 | |
| >35 | 37.25 ± 5.85 | ||
| Child-Pugh classification | |||
| A | 37.25 ± 4.06 | 0.044 | 0.144 |
| B | 17.21 ± 6.50 | ||
| AFP (ng/mL) | |||
| ≤20 | 41.25 ± 10.70 | 0.247 | |
| 20–400 | 35.54 ± 5.29 | ||
| ≥400 | 25.61 ± 4.40 | ||
| Tumor size (cm) | |||
| ≤8 | 38.26 ± 4.39 | 0.014 | 0.000 |
| >8 | 19.54 ± 3.25 | ||
| Number of tumors | |||
| Single | 37.25 ± 6.94 | 0.216 | |
| Multiple | 35.54 ± 7.42 | ||
| TACE (before RT) | |||
| No | 14.98 ± 3.18 | 0.000 | 0.000 |
| Yes | 38.46 ± 3.95 | ||
| TACE (after RT) | |||
| No | 37.25 ± 7.12 | 0.269 | |
| Yes | 28.49 ± 7.68 | ||
| RT modality | |||
| IG-IMRT | 44.66 ± 7.78 | 0.046 | 0.012 |
| 3D-CRT | 24.07 ± 6.47 | ||